COVID-19 & NSAIDs controversy:
PROCURMAX, a solution.
Commonly used NSAIDs to relief pain and inflammation have been a major concern lately due to the rumours suggesting that it could worsen symptoms of Covid-19. Despite the lack of evidence, in the past NSAIDs have been reported to reduce antibody production and weaken the immune system. Given the current situation, dietary supplements are a solid thriving alternative.
PROCURMAX: A SAFE WAY TO DISSIPATE PAIN AND REDUCE INFLAMMATION EFFECTIVELY.
PROCURMAX is an innovative bio-optimized formulation of CURSOL®, Osteolive® and tyndallized probiotic Lactobacillus paracasei Nu-09, which has been clinically demonstrated to reduce inflammatory processes as well as associated pain in muscular or joint problems.
PROCURMAX REDUCES INFLAMMATION AND RELIEVES PAIN BY 40%
CURSOL®: A highly bioavailable curcumin with potent anti-inflammatory properties. It inhibits IκB Kinase, preventing the activation of the proinflammatory pathway NFκB.
Osteolive®: Extracted from olive fruit, maslinic acid inhibits NFκB pathway, PKC activation and PLA2 enzyme, reducing the substrate for prostaglandin synthesis, a key component in the immune response.
Lactobacillus paracasei Nu-09: Balances the Th1/Th2 immune response. It reduces proinflammatory cytokine levels (IL-1β, TNF-α) and stimulates production of anti-inflammatory cytokines (IL-10).
High safety profile. No adverse reactions have been registered in our clinical trials.
PROCURMAX is a fast acting, synergistic combination of ingredients that effectively reduce inflammation, relief pain and improve GI Health, physical activity and quality of life.
K. Willsher , (2020) Anti-inflammatories may aggravate Covid-19, France advises, The Guardian
Voiriot G. et al. (2019) Risks related to the use of non-steroidal anti-inflammatory drugs in community-acquired pneumonia in adult and pediatric patients. J Clin Med 8: 786
Bancos S. et al (2009) Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells. Cell Immunol. 258:18-28
Wen YC et al (2017) Acute Respiratory Infection and use of nonsteroidal anti-inflammatory drugs on risk of acute myocardial infarction: A nationwide case-crossover study. J Infect Dis 215(4): 503-509
Huemer HP (2015) Possible immunosuppresive effects of drug exposure and environmental and nutritional effects on infection and vaccination Mediators Inflamm. 349176